Newsquawk Logo

Johnson & Johnson (JNJ) said to consider sale of orthopaedics unit at USD 20bln valuation, Bloomberg reports

Johnson & Johnson's reported consideration of a sale of its orthopaedics unit at a $20 billion valuation signals a potential strategic shift aimed at unlocking shareholder value.

Newsquawk StaffPublished On the live feed at — 1 more headline followed before this page went public
Newsquawk headlinesUTC

Fed's Miran (voter) now sees a less accommodative rate path, according to an interview in The Peg; he would reverse his Dec. shift toward easier policy if he is still at the Fed by the March meeting, citing firmer labour data and renewed goods inflation

Trump appears ready to attack Iran as US strike force takes shape, Washington Post reports

Johnson & Johnson (JNJ) said to consider sale of orthopaedics unit at USD 20bln valuation, Bloomberg reports

Coca-Cola (KO) raises quarterly dividend c. 4% to USD 0.53/shr (prev. 0.51)

[CALENDAR ADDITION] Fed's Musalem (2028 voter) to be interviewed at 20:30GMT/15:30EST on Friday by Fox Business' Edward Lawrence

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

This move could attract interest from both financial and strategic buyers, impacting its stock as investors weigh the benefits of divesting a significant division against future growth potential in its remaining businesses.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.